Literature DB >> 27652819

NSAIDs and cardiovascular risk.

Fabio Marsico1, Stefania Paolillo, Pasquale P Filardi.   

Abstract

NSAIDs are the most largely used class of drugs in the world, due to their large use in many diseases, in particular for the systemic inflammatory diseases. Nevertheless, today NSAIDs are less used for some of these diseases, due to several side-effects correlated to these drugs. The antiinflammatory mechanism of NSAIDs consist in the inibhition of two forms of cyclooxygenase, namely COX-1 (its block contributes to an antiplatelet effect) and COX-2 (its block has a greater antiinflammatory, antipyretic and analgesic effect). The COX-2 inhibition might reduce the risk of gastrointestinal toxicity, but several studies have shown the cardiovascular side effects of this inhibition. Mechanisms of the cardiovascular side effects are controversial yet, so the aim of this document is to review side-effects profile of NSAIDs and, specifically, to investigate cardiovascular consequences of NSAIDs use in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27652819     DOI: 10.2459/JCM.0000000000000443

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  17 in total

1.  Chronic pain, cardiovascular health and related medication use in ageing African Americans with osteoarthritis.

Authors:  Staja Q Booker; Virginia G Content
Journal:  J Clin Nurs       Date:  2020-05-05       Impact factor: 3.036

2.  Aspirin potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer by targeting GRP78 activity.

Authors:  Xiangyu Zhang; Jia Chen; Cheng Cheng; Ping Li; Fangfang Cai; Huangru Xu; Yanyan Lu; Nini Cao; Jia Liu; Jigang Wang; Zi-Chun Hua; Hongqin Zhuang
Journal:  Ther Adv Med Oncol       Date:  2020-09-17       Impact factor: 8.168

3.  Structural basis for selective inhibition of human PKG Iα by the balanol-like compound N46.

Authors:  Liying Qin; Banumathi Sankaran; Sahar Aminzai; Darren E Casteel; Choel Kim
Journal:  J Biol Chem       Date:  2018-05-16       Impact factor: 5.157

Review 4.  Mitral Valve Interventions in Structural Heart Disease.

Authors:  Matteo Saccocci; Maurizio Taramasso; Francesco Maisano
Journal:  Curr Cardiol Rep       Date:  2018-05-17       Impact factor: 2.931

Review 5.  A novel plausible mechanism of NSAIDs-induced apoptosis in cancer cells: the implication of proline oxidase and peroxisome proliferator-activated receptor.

Authors:  Adam Kazberuk; Ilona Zareba; Jerzy Palka; Arkadiusz Surazynski
Journal:  Pharmacol Rep       Date:  2020-07-24       Impact factor: 3.024

6.  Prevalence of non-steroidal anti-inflammatory drugs (NSAIDs) use in patients with hypertensive crisis.

Authors:  Soodeh Jahangiri; Seyed Hamidreza Mousavi; Mohammad Reza Hatamnejad; Maryam Salimi; Hamed Bazrafshan
Journal:  Health Sci Rep       Date:  2022-01-12

7.  miR-150-5p inhibits osteogenic differentiation of fibroblasts in ankylosing spondylitis by targeting VDR.

Authors:  Yuan Li; Wufang Qi; Yuquan Shi
Journal:  Exp Ther Med       Date:  2022-02-15       Impact factor: 2.447

Review 8.  Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review.

Authors:  Giacomo Dal Bello; Paolo Gisondi; Luca Idolazzi; Giampiero Girolomoni
Journal:  Rheumatol Ther       Date:  2020-04-18

9.  The Anti-Inflammatory and Uric Acid Lowering Effects of Si-Miao-San on Gout.

Authors:  Ling Cao; Tianyi Zhao; Yu Xue; Luan Xue; Yueying Chen; Feng Quan; Yu Xiao; Weiguo Wan; Man Han; Quan Jiang; Liwei Lu; Hejian Zou; Xiaoxia Zhu
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

Review 10.  Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?

Authors:  Christopher J Esh; Bryna C R Chrismas; Alexis R Mauger; Lee Taylor
Journal:  Pharmacol Res Perspect       Date:  2021-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.